HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Real estate investment trusts
Sub-IndustrySpecialized REITs
SectorFinance
SymbolNYSE:HCP
CUSIP40414L10
Phone949-407-0700
Debt
Debt-to-Equity Ratio1.37
Current Ratio0.51
Quick Ratio0.51
Price-To-Earnings
Trailing P/E Ratio13.22
Forward P/E Ratio14.16
P/E Growth6.61
Sales & Book Value
Annual Sales$1.85 billion
Price / Sales6.55
Cash Flow$2.0396 per share
Price / Cash12.64
Book Value$11.93 per share
Price / Book2.16
Profitability
EPS (Most Recent Fiscal Year)$1.95
Net Income$414.16 million
Net Margins3.39%
Return on Equity1.12%
Return on Assets0.45%
Miscellaneous
Employees190
Outstanding Shares469,830,000
Market Cap$12.37 billion
HCP (NYSE:HCP) Frequently Asked Questions
What is HCP's stock symbol?
HCP trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCP."
How often does HCP pay dividends? What is the dividend yield for HCP?
HCP declared a quarterly dividend on Thursday, July 26th. Stockholders of record on Wednesday, August 8th will be paid a dividend of $0.37 per share on Tuesday, August 21st. This represents a $1.48 annualized dividend and a dividend yield of 5.74%. The ex-dividend date of this dividend is Friday, August 3rd. View HCP's Dividend History.
How were HCP's earnings last quarter?
HCP, Inc. (NYSE:HCP) released its quarterly earnings data on Thursday, August, 2nd. The real estate investment trust reported $0.19 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.46 by $0.27. The real estate investment trust had revenue of $469.60 million for the quarter, compared to analyst estimates of $463.94 million. HCP had a net margin of 3.39% and a return on equity of 1.12%. HCP's revenue was up 2.3% on a year-over-year basis. During the same quarter last year, the company earned $0.48 earnings per share. View HCP's Earnings History.
When is HCP's next earnings date?
What guidance has HCP issued on next quarter's earnings?
HCP updated its FY18 earnings guidance on Thursday, August, 2nd. The company provided EPS guidance of $1.65-1.69 for the period, compared to the Thomson Reuters consensus estimate of $1.81.
What price target have analysts set for HCP?
15 brokers have issued 1 year target prices for HCP's shares. Their forecasts range from $21.00 to $29.00. On average, they anticipate HCP's stock price to reach $26.5357 in the next year. This suggests a possible upside of 2.9% from the stock's current price. View Analyst Price Targets for HCP.
What is the consensus analysts' recommendation for HCP?
15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HCP in the last year. There are currently 2 sell ratings, 9 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for HCP.
What are Wall Street analysts saying about HCP stock?
Here are some recent quotes from research analysts about HCP stock:
- 1. Cantor Fitzgerald analysts commented, "We are initiating coverage of HCP with a $28 price target and a Neutral rating. HCP has risen by 16% over the past three months, along with other large-cap REITs, but it is down 17.5% over the past year, compared with a 14% gain in the 12% decline in the S&P U.S. Healthcare REIT Index. We believe that most of the stock’s relative weakness reflects concern about interest rates, deteriorating fundamentals in senior housing and HCP’s restructuring. With HCP’s restructuring nearly at an end, we expect investors to begin valuing the company more on its fundamentals, which we expect to improve, and to worry less about interest rates. Although we think senior housing could remain slow for awhile, we are enthusiastic about HCP’s strategy to leverage its position in life science and MOB." (8/7/2018)
- 2. According to Zacks Investment Research, "HCP’s second-quarter 2018 funds from operations (FFO) as adjusted of 47 cents per share surpassed the Zacks Consensus Estimate by a whisker. Further, the company reported higher revenues and net operating income (NOI) on a year-over-year basis. Encouragingly, it increased the guidance for 2018 FFO per share. The company has undertaken strategic portfolio-repositioning measures in a bid to improve the quality of the senior housing portfolio and lower the Brookdale Senior Living operator concentration by selling assets in its portfolio. Further, shares of HCP have outperformed the industry it belongs to over the past three months. Although efforts to reduce the Brookdale concentration are a strategic fit for the long term, the dilutive impact on earnings in the near term from the sale of assets is unavoidable. Further, soft seniors housing market fundamentals amid new supply is anticipated to thwart the company’s pricing power." (8/7/2018)
Who are some of HCP's key competitors?
Some companies that are related to HCP include CROWN CASTLE In/SH SH (CCI), Prologis (PLD), Public Storage (PSA), Equinix (EQIX), AvalonBay Communities (AVB), Weyerhaeuser (WY), Equity Residential (EQR), Welltower (WELL), DIGITAL RLTY TR/SH (DLR), UNIBAIL-RODAMCO/ADR (UNRDY), GGP (GGP), Ventas (VTR), Boston Properties (BXP), SBA Communications (SBAC) and Realty Income (O).
Who are HCP's key executives?
HCP's management team includes the folowing people:
- Mr. Thomas M. Herzog, Pres, CEO & Director (Age 55)
- Mr. Peter A. Scott, Exec. VP & CFO (Age 38)
- Mr. Thomas M. Klaritch, Exec. VP & COO (Age 60)
- Mr. Troy E. McHenry, Exec. VP, Gen. Counsel & Corp. Sec. (Age 45)
- Mr. Scott M. Brinker, Exec. VP & Chief Investment Officer (Age 41)
Who are HCP's major shareholders?
HCP's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Hexavest Inc. (0.28%), Timbercreek Investment Management Inc. (0.17%), Aperio Group LLC (0.09%), Bank of Montreal Can (0.08%), Manning & Napier Group LLC (0.05%) and Andra AP fonden (0.04%). Company insiders that own HCP stock include Kendall K Young, R Kent Griffin Jr, Scott A Anderson and Thomas Klaritch. View Institutional Ownership Trends for HCP.
Which major investors are selling HCP stock?
HCP stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Sumitomo Mitsui Asset Management Company LTD, Timbercreek Investment Management Inc., Andra AP fonden, Nisa Investment Advisors LLC, CenturyLink Investment Management Co, Fiduciary Financial Services of The Southwest Inc. TX and Wendell David Associates Inc.. View Insider Buying and Selling for HCP.
Which major investors are buying HCP stock?
HCP stock was purchased by a variety of institutional investors in the last quarter, including Bank of Montreal Can, We Are One Seven LLC, Contravisory Investment Management Inc., First Hawaiian Bank, Lourd Capital LLC, Aperio Group LLC, Spearhead Capital Advisors LLC and Peoples Financial Services CORP.. Company insiders that have bought HCP stock in the last two years include Kendall K Young and R Kent Griffin Jr. View Insider Buying and Selling for HCP.
How do I buy shares of HCP?
Shares of HCP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is HCP's stock price today?
One share of HCP stock can currently be purchased for approximately $25.78.
How big of a company is HCP?
HCP has a market capitalization of $12.37 billion and generates $1.85 billion in revenue each year. The real estate investment trust earns $414.16 million in net income (profit) each year or $1.95 on an earnings per share basis. HCP employs 190 workers across the globe.
What is HCP's official website?
How can I contact HCP?
HCP's mailing address is 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614. The real estate investment trust can be reached via phone at 949-407-0700 or via email at [email protected]
MarketBeat Community Rating for HCP (NYSE HCP)
MarketBeat's community ratings are surveys of what our community members think about HCP and other stocks. Vote "Outperform" if you believe HCP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCP will underperform the S&P 500 over the long term. You may vote once every thirty days.
